Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2003
11/05/2003EP1154996B1 Aroyl aminoacyl pyrroles for use in the treatment of neuropathic pain
11/05/2003EP1135136B1 Pharmaceutical compositions containing olanzapine-n-oxide
11/05/2003EP1107973B1 NOVEL THIENO[2,3-d]PYRIMIDINEDIONES, PROCESS FOR THEIR PREPARATION AND USE THEREOF IN THERAPY
11/05/2003EP1054857B1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors
11/05/2003EP1037670B1 Agent for gene therapy of tumor, neurodegenerative, cardiovascular and autoimmune diseases
11/05/2003EP1023069B1 Nicotine compositions and methods of formulation thereof
11/05/2003EP0989985B1 Fused polycyclic 2-aminopyrimidine derivatives as protein kinase inhibitors
11/05/2003EP0971930B1 Process for preparing single enantiomer narwedine
11/05/2003EP0839145B1 Heterocyclylcarboxamide derivatives and their use as therapeutic agents
11/05/2003EP0839039B1 Paroxetine controlled release compositions
11/05/2003EP0715517B1 Estrene steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions
11/05/2003CN1454256A The high bone mass gene of 11q13.3
11/05/2003CN1454216A Antibodies to CCR5
11/05/2003CN1454215A Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
11/05/2003CN1454209A 1-benzyl-4-[(5, 6-dimethoxy-2-fluoro-1-indanon)-2-yl] methylpiperidine
11/05/2003CN1454204A IL-8 receptor antagonists
11/05/2003CN1454203A Substituted nitrated catechols their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them
11/05/2003CN1454095A A pharmaceutical composition for treating headache disease and process and uses thereof
11/05/2003CN1454091A Immunostimulatory nucleic acids
11/05/2003CN1454087A The use of scopolamine salts
11/05/2003CN1454086A High affinity small molecule C5A receptor modulators
11/05/2003CN1453275A Novel indodyl oxazole compound and its prepn. and application
11/05/2003CN1453029A Chinese medicine composition for treating senile dementia
11/05/2003CN1453028A Chinese medicine for treating vascular dementia and its prepn
11/05/2003CN1453025A Plant leaven with hot and fragrant smell of propylene sulfide and its prepn and use
11/05/2003CN1452999A Chinese patent medicine for treating vascular dementia
11/05/2003CN1452972A Plant extractive composition containing ginkgetin and its use
11/05/2003CN1452959A Application of maltol in preventing and treating neuroretrogressive diseases
11/05/2003CN1452957A Ainfbutomon hydrochloride prepn
11/05/2003CN1126753C Pyrazolo (3,4-D) pyrimidines for anticonvulsive and antialiergic/antiasthmatic action
11/05/2003CN1126747C Novel 2-aminothiazol-fused 2-aminoindans and 2-aminotetralines and application thereof
11/05/2003CN1126739C Novel substituted tetrahydropyridin derivatives, method for preparing the same and pharmaceutical composition thereof
11/05/2003CN1126546C Reduction of infarction region using citicoline
11/04/2003US6642478 Method for forming a via hole, flexible wiring board using the method, and method for producing the flexible wiring board
11/04/2003US6642410 Useful as antiproliferative agents, including, for example, anticancer agents
11/04/2003US6642275 Formulation for respiratory tract administration
11/04/2003US6642267 Side effect reduction over opioid analgesics; analgesic and/or anxiolytic action
11/04/2003US6642264 Thiazolobenzoimidazole derivatives
11/04/2003US6642262 Therapy for amyotropic lateral sclerosis
11/04/2003US6642258 Use of central cannabinoid receptor antagonist for preparing medicines
11/04/2003US6642257 Agents for treating neuropathic pain
11/04/2003US6642256 Brain disorders, psychological disorders, antiischemic agents, central nervous system disorders
11/04/2003US6642252 Anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in treating cancer.
11/04/2003US6642247 Treting anxiety, stress, depression, trauma, Alzheimer's mediated memory loss, epilepsy, arterial blood pressure disorders, obesity, acute pain, chronic pain, Na+ excretion, control of water balance, and symptoms associated with drug
11/04/2003US6642246 Quinuclidine acrylamides
11/04/2003US6642240 Treating emesis in a mammal
11/04/2003US6642235 Administering a therapeutically effective amount of a formulation comprising compound having a pharmacological selectivity of serotonin (Ki)/norepinephrine (Ki) of 5000; for selectively inhibiting reuptake of norepinephrine
11/04/2003US6642233 Strong affinity and high selectivity for the human NK1 receptors of substance P.
11/04/2003US6642232 3-[4-Substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2- indolinone derivatives as kinase inhibitors
11/04/2003US6642230 Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
11/04/2003US6642229 3-Phenyl-imidazo-pyrimidine derivatives as ligands for GABA receptors
11/04/2003US6642227 Such as 2-methylsulfanyl-5-(2-phenylamino-pyrimidin-4-yl)-4-p-tolyl-thiophene-3 -carbonitrile; antiproliferative agents; stents
11/04/2003US6642226 Such as cis-(3,5-bis-trifluoromethyl-phenyl)-(4-(4-methyl-piperazin-1-yl),-3-phenyl -piperidin-1-yl)-methanone; for treatment of diseases related to neurokinin receptors
11/04/2003US6642223 Benzoheterocyclic derivatives
11/04/2003US6642222 Pyrano, piperidino, and thiopyrano compounds and methods of use
11/04/2003US6642218 (5Z,7E,22E)-(1S,3R,24R)-25-(5-Propyloxazol-2-yl)-26,27-cyclo -9,10-secocholesta-5,7,10(19), 22-tetraene-1,3,24-triol for treatment of diseases characterized by hyperproliferation and deficient cell differentiation
11/04/2003US6642008 Assays and therapies for latent viral infection
11/04/2003US6641810 Methods of using geldanamycin and FK506 to treat peripheral nerve damage
11/04/2003CA2266006C Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
11/04/2003CA2175470C Novel pharmaceutical composition for the preparation of a stable powder containing an active principle comprising an association of acetylsalicylic acid and metoclopramide
11/04/2003CA2096515C Benzo[b]thiophen-3-yl-piperazines, a process for their preparation and their use as medicaments
10/2003
10/31/2003CA2444598A1 Compositions useful as inhibitors of gsk-3
10/30/2003WO2003089934A2 Method for diagnosing inflammatory diseases and infections by the determination of lasp-1/lap-1
10/30/2003WO2003089619A2 Placental derived stem cells and uses thereof
10/30/2003WO2003089608A2 Drg11-responsive (dragon) gene family
10/30/2003WO2003089573A2 Methods of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof
10/30/2003WO2003089470A1 Peptides capable of inducing attraction to the axonal growth and their use for treating neurodegenerative diseases
10/30/2003WO2003089457A2 Peptide inhibitors of protein kinase c ϝ for pain management
10/30/2003WO2003089456A2 Peptide inhibitors of protein kinase c
10/30/2003WO2003089449A2 Aminoalkyl sterol compounds having an anti-tumoral and neuroprotective activity
10/30/2003WO2003089438A1 Labeled oxazinocarbazoles as diagnostic agents
10/30/2003WO2003089434A2 IMIDAZO[1,2-a]PYRAZIN-8-YLAMINES METHOD OF MAKING AND METHOD OF USE THEREOF
10/30/2003WO2003089430A1 Thioxanthine derivatives as myeloperoxidase inhibitors
10/30/2003WO2003089429A1 Process for 5-[[2(r)-[1(r)-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3(s)-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3h-1,2,4-triazol-3-one
10/30/2003WO2003089419A1 New 2-substituted -1,3-thiazole compounds
10/30/2003WO2003089411A1 Derivatives of n-[phenyl(piperidin-2-yl)methyl]benzamide, the preparation method thereof and application of same in therapeutics
10/30/2003WO2003089410A1 Phenylalanine derivative
10/30/2003WO2003089409A1 Compounds having affinity at 5ht2c receptor and use thereof in therapy
10/30/2003WO2003089405A1 Derivatives of hydroxyphenyl, a method for preparing thereof and their pharmaceutical composition
10/30/2003WO2003088992A1 Novel screening method
10/30/2003WO2003088987A1 Composition obtained from barley shochu stillage and having effects of inhibiting the onset of alcoholic liver injury and healing it as well as favorable taste, and process for producing the same
10/30/2003WO2003088977A1 (20S)-1α-HYDROXY-2α-METHYL AND 2β-METHYL-19-NOR-VITAMIN D3 AND THEIR USES
10/30/2003WO2003088972A1 Novel compounds
10/30/2003WO2003088970A2 Modulators of hedgehog signaling pathways, compositions and uses related thereto
10/30/2003WO2003088967A1 (1-4-piperidinyl) benzimidazole derivatives useful as histamine h3 antagonists
10/30/2003WO2003088959A2 Treatment of parkinson's disease with cyclooxygenase-2 (cox 2) inhibitor(s)
10/30/2003WO2003088958A2 Combinations of cox-2 inhibitors and other agents for the treatment of parkinson’s disease
10/30/2003WO2003088945A1 Aerosol containing a particulate active substance
10/30/2003WO2003088927A2 Novel curcumin analogues and uses thereof
10/30/2003WO2003088908A2 Heterocyclo inhibitors of potassium channel function
10/30/2003WO2003088905A2 Compositions and minimally invasive methods for treating incomplete tissue repair
10/30/2003WO2003088904A2 Screening and therapeutic methods for treating circadian rhythm disorders
10/30/2003WO2003088900A2 Solid forms of salts with tyrosine kinase activity
10/30/2003WO2003088765A2 Functional foods containing a phospholipid-containing stable matrix
10/30/2003WO2003088761A2 Physiologically compatible, phospholipid-containing, stable and hard matrix
10/30/2003WO2003088748A1 Use of heme oxygenase-1 and products of heme degradation
10/30/2003WO2003066629A3 Heteroaryl compounds useful as inhibitors of gsk-3
10/30/2003WO2003066579A3 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
10/30/2003WO2003053330A3 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer’s disease and conditions associated with glycogen synthase kinase-3
10/30/2003WO2003052095A3 Use of a lysolipid for the preparation of a composition for transfection of a polynucleotide into a cell
1 ... 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 ... 1833